BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29535720)

  • 1. T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.
    Aragoneses-Fenoll L; Ojeda G; Montes-Casado M; Acosta-Ampudia Y; Dianzani U; Portolés P; Rojo JM
    Front Immunol; 2018; 9():332. PubMed ID: 29535720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
    Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
    Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis.
    Montes-Casado M; Ojeda G; Criado G; Rojo JM; Portolés P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.
    Dong S; Harrington BK; Hu EY; Greene JT; Lehman AM; Tran M; Wasmuth RL; Long M; Muthusamy N; Brown JR; Johnson AJ; Byrd JC
    J Clin Invest; 2019 Jan; 129(1):122-136. PubMed ID: 30457982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3-Kinase p110α Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice.
    Rojo JM; Montes-Casado M; Aragoneses-Fenoll L; Ojeda G; Dianzani U; Portolés P
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RP105 Engages Phosphatidylinositol 3-Kinase p110δ To Facilitate the Trafficking and Secretion of Cytokines in Macrophages during Mycobacterial Infection.
    Yu CH; Micaroni M; Puyskens A; Schultz TE; Yeo JC; Stanley AC; Lucas M; Kurihara J; Dobos KM; Stow JL; Blumenthal A
    J Immunol; 2015 Oct; 195(8):3890-900. PubMed ID: 26371254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradoxical effects of lead in interferon-gamma knockout BALB/c mice.
    Gao D; Kasten-Jolly J; Lawrence DA
    Toxicol Sci; 2006 Feb; 89(2):444-53. PubMed ID: 16280381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation.
    Hoyer KK; Herling M; Bagrintseva K; Dawson DW; French SW; Renard M; Weinger JG; Jones D; Teitell MA
    J Immunol; 2005 Jul; 175(2):864-73. PubMed ID: 16002684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
    Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N
    J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.
    So L; Yea SS; Oak JS; Lu M; Manmadhan A; Ke QH; Janes MR; Kessler LV; Kucharski JM; Li LS; Martin MB; Ren P; Jessen KA; Liu Y; Rommel C; Fruman DA
    J Biol Chem; 2013 Feb; 288(8):5718-31. PubMed ID: 23275335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).
    Acosta YY; Zafra MP; Ojeda G; Bernardone IS; Dianzani U; Portolés P; Rojo JM
    Cell Mol Life Sci; 2011 Sep; 68(18):3065-79. PubMed ID: 21188463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
    Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
    Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ.
    Madireddi S; Schabowsky RH; Srivastava AK; Sharma RK; Yolcu ES; Shirwan H
    PLoS One; 2012; 7(8):e42459. PubMed ID: 22870329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-27 signaling promotes immunity against endogenously arising murine tumors.
    Natividad KD; Junankar SR; Mohd Redzwan N; Nair R; Wirasinha RC; King C; Brink R; Swarbrick A; Batten M
    PLoS One; 2013; 8(3):e57469. PubMed ID: 23554861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway.
    Tu CT; Li J; Wang FP; Li L; Wang JY; Jiang W
    Int Immunopharmacol; 2012 Dec; 14(4):410-21. PubMed ID: 22940540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.
    Papotto PH; Marengo EB; Sardinha LR; Carvalho KI; de Carvalho AE; Castillo-Mendez S; Jank CC; Vanhove B; Goldberg AC; Rizzo LV
    PLoS One; 2017; 12(3):e0171822. PubMed ID: 28248972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.